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Inhaler Technique Education and Exacerbation Risk in Older
Adults with Asthma or Chronic Obstructive Pulmonary Disease:
A Meta-Analysis
Tiago Maricoto, MD,*† Luís Monteiro, MD,†‡ Jorge M.R. Gama, PhD,§
Jaime Correia-de-Sousa, MD,¶k and Luís Taborda-Barata, MD**††‡‡
OBJECTIVES: To evaluate the effect of inhaler education
programs on clinical outcomes and exacerbation rates in older
adults with asthma or chronic obstructive pulmonary dis-
ease (COPD).
DESIGN: Systematic review and meta-analysis.
SETTING AND PARTICIPANTS: Older adults with
asthma or COPD, either in primary or secondary health
care and pharmacy setting.
MEASUREMENTS: We searched the Medline, Embase, and
Central databases according to the main eligibility criteria for
inclusion: systematic reviews, meta-analysis, clinical trials and
quasi-experimental studies; participants aged 65 and older;
education on inhaler technique and reporting of disease con-
trol and exacerbation rates. We used the Grading of Recom-
mendations, Assessment, Development and Evaluations scale
for quality assessment and used a random-effect model with
Mantel–Haenszel adjustment to perform a meta-analysis.
RESULTS: We included 8 studies (4 randomized, 4 quasi-
experimental) with a total of 1,812 participants. The most fre-
quent type of intervention was physical demonstration of
inhaler technique, training with placebo devices. Five studies
showed significant reduction in exacerbation rates (pooled risk
ratio=0.71, 95% confidence interval=0.59–0.86; p < .001),
although effect on disease control and quality of life showed
high discrepancy in the reported results, and all randomized
studies revealed uncertainty in their risk of bias assessment.
CONCLUSION: All interventions seemed to improve inhaler
performance and clinically relevant outcomes, but a placebo
device could be the most effective. There is evidence that inter-
ventions reduce exacerbation risk in older adults, although to
an overall moderate degree. J Am Geriatr Soc 00:1–10, 2018.
Key words: asthma; chronic obstructive pulmonary dis-
ease; inhalers
Asthma and chronic obstructive pulmonary disease(COPD) affect up to 10% of the population, and many
individuals with these conditions have uncontrolled symp-
toms.1 They experience frequent exacerbations, some of which
can be life threatening. Up to 53% of community-treated indi-
viduals may experience exacerbations, and good adherence to
therapy is associated with reductions in exacerbations in half
of cases.2–4 Inhaled therapy is the most widely used treatment,
but up to 90% of individuals used incorrect technique in clini-
cal studies,5 partly because the extensive variety of inhalers
and their technical specifications create significant barriers to
understanding of proper use.6 Although all available inhalers
may be equally efficient when properly used,7 there are vari-
ous device- and person-related factors that may significantly
influence performance.8–11 Poor inhaler technique is associated
with worse symptom control12,13 and leads to greater health-
care resource consumption and costs.14
Some studies have showed that teaching inhaler tech-
nique may lower the risk of exacerbations and death in these
individuals,2,3,15–17 but the effect of teaching decreases with
time, indicating the importance of regular reassessment.9,18,19
There are many tools for teaching inhaler technique,20 and
two systematic reviews have addressed this. One concluded
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that there is lack of evidence about which is the best educa-
tion method to improve inhaler technique.21 The other con-
cluded that there is sufficient evidence of the efficacy of
different inhaler educational strategies, but the authors did
not quantify this effect with precision because it did not
include a meta-analysis.22 In addition, neither review focused
on older adults.
Inhaler technique performance is regarded as particu-
larly complex in older adults with asthma or COPD, who
also tend to have lower inhaler adherence rates.19,23,24
These individuals find it more difficult than younger adults
to use the devices correctly, with several characteristics
seeming to hamper them, such as cognitive impairment, low
education level, osteoarthritis, and global frailty.23,25–28 For
such reasons, and because these conditions are frequently
underdiagnosed, elderly adults are more susceptible to dis-
ease consequences and exacerbations29,30 and are fre-
quently excluded from clinical trials of education programs.
Thus, there is a lack of evidence regarding the real effect
that educational interventions have in these individuals.
Our systematic review and meta-analysis assessed whether
there is evidence that inhaler technique education in older
adults with asthma or COPD improves clinical control and
reduces disease exacerbations. We also analyzed which is
the best method for teaching inhaler technique and how
often it should be taught.
METHODS
Eligibility Criteria
Search Criteria Following a Population, Intervention, Com-
parator, Outcomes Format
Participants
We selected studies that included (not exclusively) partici-
pants aged 65 and older with asthma or COPD. In studies
aggregating adults and older adults, we used the average
age to decide on inclusion. Studies with mean age between
60 and 65 were included in preliminary analyses to assess
their magnitude of influence on our major results and con-
clusions and were included in detailed analysis if considered
highly relevant.
Intervention
We defined as the main criteria interventions that focus on
teaching inhalation technique and, provided by health pro-
fessionals and directed to patients or their caregivers, what-
ever method used (e.g., oral instructions and physical
demonstration with placebo device, text-based print
resources, media, educational tools (e.g., turbutest, In-
CheckDial), e-health interventions, combinations thereof ).
We included studies involving hospital staff (e.g., clinicians,
nurses), pharmacists, general practitioners, community
health workers, and others as providers.
Comparator
Different methods were compared with one another or pla-
cebo or usual care (treatment provided in a real-world
scenario, according to local guidelines or healthcare pro-
vider judgments).
Outcomes
We included studies that addressed any of the following
outcomes: inhaler performance evaluation (change from
baseline scores preferred); all-cause hospitalization or all-
cause mortality; exacerbation rate or loss of control; clinical
control (preferably measured on a validated scale); quality
of life (preferably measured on a validated scale); functional
control (e.g., as change from baseline scores in forced expi-
ratory volume in the first second (FEV1), forced vital capac-
ity (FVC), FEV1/FVC ratio, peak expiratory flow (PEF))
Types of studies
We searched systematic reviews, meta-analyses, randomized
controlled trials (RCTs), nonrandomized clinical trials, and
quasi-experimental studies. We included quasi-randomized
studies because of the lack of RCTs to reinforce the quality
of our review and confidence in our findings.
Search Methods
We used the EMBASE, CENTRAL, and MEDLINE data-
bases as primary sources and reference lists from studies
included in primary sources and those found by author
review and expert opinion as secondary sources. We also
screened the main trial registry databases, such as the
U.S. National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (www.clinicaltrials.gov) and the World
Health Organization International Clinical Trials Registry
Platform (apps.who.int/trial search).
We used the Medical Subject Heading terms “nebu-
lizers and vaporizers,” “asthma,” and “pulmonary disease,
chronic obstructive,” with a time limit for publication of
March 2017.
Overall, we intended to reproduce the same search
strategy of previous systematic reviews that addressed the
same questions (see detailed search strategies in Supplemen-
tary Appendix S1).
Selection Process
Two independent, blinded authors (TM, LM) selected the
articles according to the defined criteria and applied the fol-
lowing filter stages: cleaning of duplicated articles, selection
of articles according to eligibility criteria and by reading the
title and abstract, and selection of articles according to full-
text reading.
Reasons for article rejection are expressed in a Pre-
ferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) diagram31 (Figure 1). All disagree-
ments, at every stage, including selection of studies, quality
assessment, and data extraction, were resolved through dis-
cussion or by a third review author (LT-B).
Data Collection Process
Two authors (TM, LM) collected data from selected articles
in their original presentation and noted them in a spread-
sheet. We also collected indirect data from figures and
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charts, adapting their interpretation by consensus, and
authors of original articles were contacted for further infor-
mation and data.
Type of Data Collected
Two authors (TM, LM) collected the following information.
General data: Year, study type, number of participants,
age, sex, follow-up time, withdrawals, diagnosis, disease
severity, type of intervention, study location, time between
interventions, type of intervention provider, adverse events
and outcomes reported.
Outcomes: Inhaler performance, adherence rate, clini-
cal control, quality of life (in any type of validated scale)
and functional control (FEV1%; FVC%, PEF%, FEV1/FVC
ratio) (in median, range, 95% confidence interval (CI), stan-
dard deviation, standard error, or any index of percentage
of change) and exacerbation rate, hospitalization, and mor-
tality (in odds ratio, risk ratio (RR), hazard rate, number
needed to treat, and their respective 95% CIs).
One author (TM) inserted data into software for pre-
paring and maintaining Cochrane Reviews (Review Man-
ager (RevMan), http://community.cochrane.org), and data
were double-checked for correct entry.
Analysis of Results and Assessment of the Risk of Bias
Two authors (TM, LM) analyzed the data according to risk
of bias using a qualitative approach. Quality of evidence for
the collected outcomes of interest and recommendation for the
interventions were assessed using the Grading of Recommen-
dations, Assessment, Development and Evaluations (GRADE)
system, as reported in the Cochrane Handbook for Systematic
Reviews of Interventions.32 Two other authors (LT-B or JCS)
confirmed this assessment.
Risk of bias was assessed in the following domains:
random sequence generation, allocation concealment, blind-
ing of participants and personnel, blinding of outcome
assessment, incomplete outcome data, selective outcome
reporting, and other biases.
Risk of bias in each study was graded as high, low, or
uncertain and justifications for such judgment were reported
in the “Risk of bias” table [Supplementary Appendix S2].
Publication bias was analyzed using a funnel plot.
Measures of Treatment Effect
Two authors (TM, JG) quantitatively analyzed RCTs to
determine effect estimations, heterogeneity, and consistency
Figure 1. Flow diagram on search and article inclusion, according to Preferred Reporting Items for Systematic Reviews and Meta-
Analysesstatement.31
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tests. We used Mantel-Haenzsel RRs with 95% CIs using a
random-effects model for dichotomous data. Continuous
outcomes were analyzed as standardized mean differences
with 95% CIs using a random-effects model, because the
included studies used different measurement instruments. We
used meta-analysis only for RCTs. Heterogeneity between
effect sizes of included studies was assessed using visual
inspection of forest plots and the chi-square test for heteroge-
neity (with P<.10), and inconsistency between trials was
described according to percentage of variability in effect esti-
mates due to heterogeneity rather than chance (I2). We also
performed sensitivity analyses of the included studies and
their effect on the meta-analysis. Results of the primary out-
come, exacerbation risk reduction, with trial sequential anal-
ysis were also presented using the O’Brien Fleming
monitoring boundaries approach. This was performed con-
sidering the results pooled in meta-analysis to exclude false-
positive or false-negative results from our review.33
No subgroup analysis was planned because of the small
number of studies. Quantitative analyses were not performed
in quasirandomized studies because of their high risk of bias.
All statistical procedures were performed using Rev-
Man, GRADEPro online (https://gradepro.org/), and trial




Our search yielded 854 articles (Figure 1). From the
802 unique articles, eight studies met the inclusion criteria and
were analyzed. Most studies were excluded because they did
not address inhaler education in elderly adults or because no
relevant outcomes were used. One study presented potential
criteria for inclusion in its abstract, but no data from out-
comes were available in full-text format, so it was excluded.34
One included study evaluated quality of life, but those results
were not published in the article.35 Authors of these publica-
tions were contacted but did not reply.
Of the eight studies included, four had a randomized
design,16,35–37 and the remaining four had a quasi-ran-
domized pre- and post-intervention design17,38–40 (details
in Supplementary Appendix S3).
1812 participants were evaluated. Five studies
addressed only COPD, one addressed asthma, and two
addressed both. Five studies were performed in secondary
health care facilities, two at community pharmacies and
one at primary health care centers. A pharmacist performed
the educational intervention in half of the studies and a
nurse or a doctor in the other half. Follow-up varied from
1 month to 2 years, and half of the studies had at least
1 year of follow-up. The mean age of participants was
slightly greater than 65 in six of the studies and younger
than 65 in the other two. We decided to include them to
reinforce the quality of our review and confidence in our
findings because the search strategy yielded few studies.
Also, these two studies had large sample sizes39 and
reported exacerbation risk as an outcome.35
Educational interventions varied between studies. Three
studies examined a physical demonstration with placebo
devices, which was the most frequent type of intervention,
covering more than half of the total amount of participants.
Two studies used video demonstration, and another two
Figure 2. Risk of bias assessment in included studies according to Grading of Recommendations, Assessment, Development and
Evaluations tool and recommended by Cochrane.32
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studies delivered written information. One study did not spec-
ify inhaler education type,35 and another one was unclear.17
Quality of life and exacerbations were the most com-
monly reported main outcomes (six studies), but different
instruments and scales were used.16,17,35–37,40 Similar limita-
tions occurred with clinical and functional control, adherence
rate, and inhaler performance evaluation. Cost-effectiveness
was never reported.
Most studies examined several aspects of intervention in
addition to inhaler technique education: self-management
plans, disease knowledge, and management of exacerbations
and their triggers. Only two studies included a repeated educa-
tion program, providing intervention every 6 months.17,40 All
the other studies provided the intervention only at baseline.
Risk of Bias in Included Studies
Two independent reviewers (TM, LM) evaluated risk of
bias of the included studies, reaching consensus in all eval-
uations (Figure 2). Nonrandomized trials were classified as
being at high risk of bias in the main parameters, such as
random sequence generation, allocation concealment,
blinding of participants and personnel, and blinding of
outcome assessment. In our review, RCTs showed an
overal uncertainty in their risk assessment, although most
of them had good blinding on random sequence genera-
tion and allocation concealment. The main limitation of
RCTs was lack of blinding of the intervention and out-
come assessment (detailed evaluation in Supplementary
Appendix S2).
Logistic regression tests were used to determine
whether there was a statistically significant relationship
between lower risk of bias and magnitude of effect in the
main reported outcomes. To build the model, we set all var-
iables as binary: risk of bias (0 = high, 1 = uncertain) and
inhaler performance, adherence rate, symptom control,
respiratory function, quality of life, and exacerbation rate
(0 = negative outcome, 1 = positive outcome). None of
these outcome variables was statistically associated with
risk of bias of included studies.
Figure 3. Meta-analysis. (a) Inhaler performance. Tommelein et al.(ref. 16) measured the global % of correct steps. Rootmensen et al.(ref. 35)
measured the global score of correct performance; (b) Exacerbation Rate. (c) Quality of Life. Tommelein et al.(ref. 16) used ED-5D scale.
Khdour et al.(ref. 36) and Bourbeau et al.(ref. 37) used St. George questionaire. (d) Respiratory function (change in forced expiratory volume
in 1 second).
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Effects of Interventions
Table 1 shows the main findings of clinical and relevant
outcomes from selected studies, and Figure 3 shows the
results of the meta-analysis.
Inhaler Performance
Only half of the studies measured the effect of the interven-
tion on inhaler performance, and all16,38,40 except one35
showed improvement. That one study did not specify the
type of tool used to teach inhaler technique, and it may not
have been the primary objective of the intervention.
Authors were contacted but did not reply. Although signifi-
cant differences were not found after the intervention, when
results were pooled in a meta-analysis together with a
RCT,16 they showed a significant effect on inhaler perfor-
mance. Nevertheless, heterogeneity was high, probably
because different measures of inhaler performance were
used. Also, the one study35 found a significant reduction in
exacerbation rate at the end of follow up, which could be
due to the additional topics covered in the intervention,
especially disease self-management skills.
Exacerbation Rate
All RCTs resulted in a significant reduction in exacerbation
rates, in the intervention group, and comparing with usual
care group.16,35–37 The reported mean RR on these studies
varied from 0.45 to 0.82, with wide CIs and favouring the
intervention group. Pooling these results in a meta-analysis,
we found a significant mean reduction of almost 30% in
exacerbation rates favouring the intervention. (RR=0.71,
95% CI=0.59–0.86) and a significant low heterogeneity
index. In addition, sensitivity analysis showed that remov-
ing any of the included studies did not affect the outcome.
Also, trial sequential analysis (Supplementary Appendix S4)
confirmed our confidence in these findings, excluding the
risk of a false-positive result, because significant boundaries
and the necessary sample size were achieved.
One quasirandomized study had the same results, with
relative reduction in exacerbation rates of almost 50%.17
One study did not show any differences.40 This was a ran-
domized study, comparing the use of a peak flow meter with
symptom monitoring as a basis for disease control, and used
physical demonstration with placebo devices in all partici-
pants, repeated every 6 months and provided by a clinician.
It had a large sample size (396 participants) and 24 months
of follow-up and participants had predominantly moderate
to severe asthma. The authors did not find a reduction in
global exacerbation rate, which could be because this study
included only individuals with asthma, whereas participants
in the other studies had COPD or both.
Disease Control
All studies evaluated the effect of intervention on several
aspects of disease control, mainly on quality of life and
symptoms. A although the results were highly discrepant
because half of the studies found improvement in these out-
comes36,37,39,40, whereas the other half did not16,17,35,38.
Meta-analysis including only RCTs did not find significant
improvement in quality of life, although a sensitivity analysis
including only the two studies that used the St. George’s
Respiratory Questionnaire36,38 showed an improvement of
3.57 points in mean score (95% CI=0.36–6.78). No relevant
characteristics seemed to differentiate the studies with regard
to these findings, but detailed analysis of the RCTs showed
that longer follow-up was associated with a more significant
positive effect on quality of life.36,38 Nevertheless, the magni-
tude of these effects was small, and with wide CIs, and was
associated with overall moderate strength of evidence.
Respiratory Function
Half of the studies evaluated effect on FEV1, but only
one showed a significant benefit of the intervention.40 In this
study, inhaler education was not the primary objective, and
all participants received a thorough disease self-management
program, with several intervention aspects in addition to
inhaler education. The magnitude of the observed effect was
small, with a wide CI. Quantitative analysis did not show
any significant benefit either.
Adherence
Three studies evaluated the effect on adherence to inhaled
medication, and all showed significant improvement after
the intervention.16,17,36 This effect may also be due to the
Hawthorne effect. Only two of the RCTs evaluated this
outcome, but they used different scales, and one did not
report useful results for quantitative analysis.
Education Frequency
Only two studies included a repeated education program,
which was mainly on a biannual basis.17,40 Both were non-
randomized and reported divergent results in the main out-
comes. Thus, we could not perform a quantitative or
sensitivity analysis on them, which limits any kind of con-
clusion about how often inhaler review and education
should be recommended.
DISCUSSION
Summary of Main Results
The main finding of our review is that inhaler technique educa-
tion can significantly reduce exacerbation risk; this is reinforced
by a significant pooled result with a low index of statistical het-
erogeneity in the meta-analysis. This is the first study to find
such results in older adults with asthma or COPD.
Interventions can also improve quality of life and clini-
cal control, but results are still divergent. Also, by enhanc-
ing self-management education, adherence also increases,
but this was difficult to quantify. These findings should be
interpreted with caution because most studies lack sufficient
quality of the evidence on their results, and this is due to
several limitations in design and methods that introduce a
high risk of bias.
Most studies addressed complex intervention aspects
beyond inhaler technique education alone, and this is par-
ticularly relevant to the outcomes of interest because it
makes it harder to determine the true effect of an inhaler
education approach alone. Thus, this review failed to
uncover any important information about the role of
inhaler technique education alone.
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Although many guidelines recommend regular inhaler
review, it is unclear how often that should be performed
with older adults.
Only one RCT included individuals with asthma,35 and
the others only had participants with COPD. Thus, individ-
uals with asthma accounted for only 6% of total analyzed
individuals, which skews the available evidence
toward COPD.
We could not perform additional subgroup analysis,
namely according to age strata (such as in patients below or
above 75 years old), or even according to important comor-
bidities (e.g., osteoarthritis, frailty, cognitive disorders). All
studies had a mean age of younger than 70 and none
reported such data. Such subgroup analysis would be clini-
cally relevant because there is increasing evidence suggest-
ing that such characteristics seem to be determinant to
inhaler performance and to disease outcomes in these
individuals.23,25,27,28
Overall Applicability and Quality of Evidence
Using the GRADE approach to rate the quality of the evi-
dence, our analysis showed a significant overall risk of bias
in studies. Half did not have a randomized design, and even
RCTs were not blinded to the intervention because of its
intrinsic nature. This introduces a potential Hawthorne
effect, which could overestimate the main outcomes.
Although this could compromise the internal validity of tri-
als, globally, all showed a regular and similar trend in the
results, indicating their external validity and applicability.
Although the included studies did not perform any
cost-effective analysis or report adverse effects of the inter-
ventions, the potential benefits may outweigh the risks,
which also favors regular inhaler education. Several studies
have highlighted these aspects.2,14,15
It is difficult, with the existing evidence, to determine the
true potential of inhaler education alone or what the most effi-
cient education method is. Some studies suggested that pla-
cebo device demonstration may be the best,41–43 but this was
not clear in our review. It is possible that older adults have
some resistance to this method because of problems such as
cognitive impairment.23,26 We found only one RCT that used
placebo device training for the intervention, and it showed
improvement in exacerbation risk only for severe episodes.16
More randomized and blinded studies are needed to test dif-
ferent types of interventions, clarify which factors may influ-
ence inhaler performance, and assess the effect of performance
on clinically relevant outcomes in older adults.
Well-trained staff with adequate time dedicated to
instruction performed these studies. This does not usually
happen in the real world, where health professionals are on
tight schedules and do not have proper training on handling
all available devices. This could undermine generalizability
of study findings.
Potential Biases in the Review Process
Our review process was based on Cochrane recommenda-
tions32 and is in accordance with the PRISMA statement,31
which makes it less susceptible to major biases and errors.
The search method was based on main databases
(CENTRAL, MEDLINE, EMBASE) and covered important
secondary sources. Criteria used were broad, yielding a rep-
resentative selection of studies. Previous systematic
reviews21,22 on the same topic were also screened for sec-
ondary sources of important studies, which minimizes the
risk of bias in this process. During the selection process, in
addition to RCTs, we included nonrandomized studies to
avoid underestimation of true effects of inhaler education
programs. Although the quality of evidence from nonrando-
mized studies is poor, we believe that all four studies
included helped reinforce the strength of recommendation
regarding some of the outcomes, namely exacerbation risk
reductions. In addition, by including quasirandomized stud-
ies, we highlight the need for further, adequately designed
research in this population.
Two independent reviewers assessed quality of evidence
using the GRADE approach, and agreement was obtained
in all studies. Two other authors confirmed the process. In
addition, the main results of this analysis are similar to
those reported in previous systematic reviews.21,22
Performing a meta-analysis of such different and com-
plex interventions could lead to false interpretation of
results, because these studies are not truly comparable. To
overcome this, we confirmed the main meta-analysis find-
ings using trial sequential analysis (Supplementary Appen-
dix S4), which strongly reinforced the finding of a
significant reduction of exacerbations, increasing confidence
in the results and excluding risk of a false-positive result.
Comparison with Other Studies and Reviews
To our knowledge, this is the first systematic review of
inhaler education in older adults with asthma or COPD
that obtained such clinically relevant results on disease con-
trol, namely the reduction of exacerbation risk. Given the
aging of the population and the complex characteristics of
these individuals, we find this work relevant and timely.
This systematic review stands out from previous ones for
several reasons.21,22 First, it focuses on older adults, who often
have poor clinical control, are more susceptible to exacerba-
tions, and often have poor inhaler technique.25,26 In addition,
we included randomized and nonrandomized studies, which
allowed us to make realistic conclusions about the effect of
inhaler technique education. Also, our review included recent
studies that were not included in previous work. Finally, our
systematic review highlights that most studies showed a posi-
tive effect of training on exacerbation risk reduction.
In a systematic review,21 the authors included only
individuals with asthma and included adults and older
adults together, without performing a subgroup analysis of
the latter. This spread of age ranges may have introduced
some bias, mainly derived from endotypic and phenotypic
disease differences, which could lead to different clinical
responses to education on inhaler performance. Another
systematic review22 focused on postintervention inhaler per-
formance as the main outcome but did not fully analyze the
clinically relevant outcomes. Also, it included a wide age
range, did not perform a subgroup analysis of older adults,
and did not include a meta-analysis. In any case, previous
work and our review indicate that inhaler technique educa-
tion improves performance and has a potential benefit for
clinical outcomes, although the strength of the evidence is
low to moderate.
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We found inconsistent results in clinical control and
quality of life, but overall, interventions seem to signifi-
cantly reduce exacerbation rates. This is particularly rele-
vant for health economics, and several studies have shown
positive, cost-effective associations in this field.2,14,15
CONCLUSIONS
Inhaler technique education is a critical aspect of self-
management programs, and different types of interventions
seem to improve inhaler performance and clinically relevant
outcomes. Review of inhaler technique is recommended,
and there is evidence that interventions that promote
improvement in inhaler technique ameliorate disease con-
trol. In addition, these interventions significantly reduce
exacerbation risk in older adults, although the strength of
evidence for these outcomes is moderate. Further studies
are warranted to compare education methods and target
populations and to define the best regular follow-up.
DIFFERENCES BETWEEN PROTOCOL AND
REVIEW
The protocol of this systematic review was registered in
PROSPERO with the number CRD42017063847, available
at: https://www.crd.york.ac.uk/PROSPERO/display_record.
asp?ID=CRD42017063847.
The study protocol differs from the final work only in
the age criteria. In the protocol, we intended to include only
studies with a mean age of participants aged 65 and older
but included two studies with a mean age slightly below
that because we found them very relevant to our objective,
and both reported important outcomes.
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Appendix S1: Search Strategy Used
Appendix S2: Quality assessment and Risk of bias
table.
Appendix S3: Complete data of selected studies.
Appendix S4: Trial sequential analysis on the primary
outcome, exacerbation risk reduction, with a two-sided
graph. The required information size to demonstrate or
reject a 25% relative risk reduction in benefit on inhaler
technique review with a usual care group proportion of
58.2%, an alpha of 5% and a beta of 80% is 527 patients
(vertical etched line), and according to heterogeneity index
found in meta-analysis. The curved etched lines represent
the trial sequential monitoring boundaries and the futility
boundaries. The solid curved line is the cumulative Z-curve.
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